Artykuły w Czytelni Medycznej o SARS-CoV-2/Covid-19

Zastanawiasz się, jak wydać pracę doktorską, habilitacyjną lub monografię? Chcesz dokonać zmian w stylistyce i interpunkcji tekstu naukowego? Nic prostszego! Zaufaj Wydawnictwu Borgis – wydawcy renomowanych książek i czasopism medycznych. Zapewniamy przede wszystkim profesjonalne wsparcie w przygotowaniu pracy, opracowanie dokumentacji oraz druk pracy doktorskiej, magisterskiej, habilitacyjnej. Dzięki nam nie będziesz musiał zajmować się projektowaniem okładki oraz typografią książki.

Poniżej zamieściliśmy fragment artykułu. Informacja nt. dostępu do pełnej treści artykułu tutaj
© Borgis - Postępy Nauk Medycznych 4/2013, s. 262-266
*Magdalena Walicka1, Wojciech Bik2, Ewa Wolińska-Witort2, Ewa Marcinowska-Suchowierska1
Wpływ płci na stężenia adipokin oraz ich korelacje z insulinoopornością u pacjentów z otyłością olbrzymią
Gender dependent dimorphism in adipokines levels and its correlations with insulin resistance in extremely obese patients
1Internal, Family Medicine and Metabolic Bone Disease Department, Medical Centre of Postgraduate Education, Warsaw
Head of Department: prof. Ewa Marcinowska-Suchowierska, MD, PhD
2Department of Neuroendocrinology, Medical Centre of Postgraduate Education, Warsaw
Head of Department: Wojciech Bik, MD, PhD
Streszczenie
Wprowadzenie. Otyłość łączy się z insulinoopornością, a insulinooporoność jest związana ze zmianami w zakresie stężeń adipokin. Zaobserwowano również różnice w stężeniach niektórych adipokin związane z płcią.
Cel pracy. Celem pracy była ocena wpływu płci na stężenia adiponektyny i jej frakcji, wisfatyny i waspiny oraz na ich korelacje z insulinoopornością u pacjentów z otyłością olbrzymią.
Materiał i metody. Do badania włączono 34 osoby z otyłością olbrzymią (BMI ≥ 40 kg/m2, 12 mężczyzn i 22 kobiety). U wszystkich oznaczono stężenia w surowicy krwi na czczo: glukozy, insuliny, adiponektyny i jej frakcji, wisfatyny, wapsiny oraz obliczono wskaźnik insulinooporności HOMA-IR.
Wyniki. Wskaźnik HOMA-IR był prawie dwukrotnie wyższy u mężczyzn niż u kobiet. U kobiet stwierdzono wyższe stężenia adiponektyny i jej frakcji HMW, leptyny i wisfatyny. Ujemną korelację między: stężeniem adiponektyny a insuliny, stężeniem adiponektyny a HOMA-IR, frakcją HMW adiponektyny a insuliną, frakcją HMW adiponektyny a HOMA-IR zaobserwowano tylko u kobiet. Dodatnią korelację między stężeniem leptyny a HOMA-IR zaobserwowano tylko u mężczyzn.
Wnioski. U pacjentów z otyłością olbrzymią występuje dymorfizm płciowy dotyczący stężeń adipokin oraz ich korelacji z insulinoopornością. Zjawisko to nie jest w pełni zrozumiałe ale może być związane z różnicami w zakresie dystrybucji tkanki tłuszczowej.
Summary
Introduction. Obesity is closely associated with insulin resistance, and insulin resistance is connected with altered adipokine levels. There are gender differences in some adipokines concentration.
Aim. The aim of this study was to evaluate sex-dependent differences in adiponectin fractions, visfatin and vaspin concentrations and gender dimorphism in association between this adipokines and insulin resistance in obesity.
Material and methods. Thirty four extremely obese (BMI ≥ 40 kg/m2) patients (12 male and 22 female) were enrolled in the study. In all subjects fasting serum glucose, insulin, adiponectin and its fractions, visfatin, vaspin concentration were measured and HOMA-IR was calculated.
Results. Men presented almost twofold higher HOMA-IR than women. Total adiponectin and HMW adiponectin, leptin and visfatin concentrations were higher in women than in men. Significant negative correlations between: total adiponectin and insulin, total adiponectin and HOMA-IR, HMW adiponectin and insulin, HMW adiponectin and HOMA-IR were observed only in female. Significant positive correlation between leptin and HOMA-IR was find only in male.
Conslusions. In extremely obese patients there is a gender dependent dimorphism in adipokines levels and their correlations with insulin resistance. This dimorphism is not fully understood and it might be due to different adipose tissue distribution.
INTRODUCTION
After the past decade discoveries, adipose tissue is no longer regarded as a simple reservoir of energy, but rather as a fundamental endocrine gland of the human body. Adipocyte-derived bioactive substances, named adipokines, are able to influence on numerous physiological and pathological processes. Moreover, adipose tissue is also the largest organ in the whole body and possesses metabolic and endocrine functions. In details, by secreting adipokines, it plays a significant role in regulating lipid and carbohydrates homeostasis, and it is thought to be the major site of steroid metabolism. It influences on vascular function. Furthermore, adipokines mediate appetite and energy balance. Disturbed secretion of adipokines resulting from excessive accumulation of adipose tissue contributes to diabetes, hyperlipidaemia and hypertension. Obesity is closely associated with insulin resistance, and, on the other hand, insulin resistance is connected with altered adipokine levels (1).
Adiponectin is secreted mainly by adipocytes of the white adipose tissue. It increases insulin sensitivity, and reveals anti-inflammatory and anti-atherosclerotic action (2). Interestingly, lower adiponectin levels were found in obesity especially in visceral adiposity (3, 4). Adiponectin circulates in serum in different complexes of multimers, from low molecular weight (LMW) trimmers, through medium molecular weight (MMW) hexamers to high molecular weight (HMW) multimers. It is believed that dependently on the form of adiponectin, different physiologic properties of this adipokine are present (5). Recent clinical and experimental studies showed that HMW form of adiponectin possesses strong anti-diabetic and anti-atherogenic properties (6, 7).
Visfatin is expressed in many tissues although initially it was reported to be released by visceral adipose tissue (8). Primary studies showed that this adipokine activates insulin receptor and presents insulin-mimetic effects, lowering blood glucose and improving insulin sensitivity (8). However, the results of further studies on the role of visfatin in glucose and lipid metabolism were contradictory (9, 10). Our current knowledge about the role of visfatin in the pathogenesis of obesity and metabolic syndrome is limited.
Vaspin (visceral adipose tissue-derived serpin; serpinA12) was originally identified as an adipokine, being predominantly secreted from visceral adipose tissue in Otsuka Long-Evans Tokushima fatty (OLETF) rats, an animal model of obesity and type 2 diabetes. Consistently, both higher vaspin serum concentrations and increased vaspin mRNA expression in human adipose tissue were found to be associated with obesity, insulin resistance and type 2 diabetes in humans. However, the precise mechanisms how vaspin secretion may be linked to deterioration of glucose metabolism and insulin sensitivity are not entirely understood yet (11, 12).
Leptin plays a key role in regulating energy intake and energy expenditure including appetite, hunger and metabolism. In physiological conditions, it reduces food intake on the brain level and enhances expenditure of energy, mainly by influencing on thermoregulation as increase in thermogenesis and metabolic rate were found (1). Besides, this adipokine is regarded as one of the most important adipose-derived hormones as pleiotropic effects of leptin have been reported. Previous studies indicated that human obesity is characterized by increased levels of circulating leptin. Despite the elevated leptin levels, which normally would be anticipated to reduce food intake and to decrease body fat, obese patients are insensitive to the action of leptin and continue to maintain increased amount of body fat (2).
Interestingly, there are gender differences seen in concentration of adipokines. Gender is a major determinant of plasma leptin concentration as women had approximately 40% higher leptin levels than men at any level of adiposity (13). Similarly, adiponectin levels are found to be greater in women (14, 15). Nevertheless, there are no available data concerning sex-dependent differences in adiponectin fractions, visfatin and vaspin concentrations. Finally, to our knowledge there is a lack of information about existing gender dimorphism in association between adiponectin fractions, visfatin, vaspin, leptin and insulin resistance in obesity.
MATERIAL AND METHODS
Subjects
Thirty four extremely obese (BMI ≥ 40 kg/m2) patients (12 male and 22 female) were enrolled in the study. All individuals were Caucasians and were recruited among patients of Department of Family, Internal Medicine and Metabolic Bone Diseases, Orlowski Hospital, Centre of Postgraduate Medical Education in Warsaw, Poland. All patients were admitted to the hospital for internal examination prior to the bariatric surgery. Exclusion criteria from the study were as follows: acute endocrine dysfunction as well as chronic kidney and liver disease. None of examined subjects had a history of excessive alcohol consumption.
The study protocol was accepted by the Bioethical Committee of the Centre of Postgraduate Medical Education. Informed consent was obtained from all study participants.
Blood analyses
Blood samples were obtained at 8.00 am after overnight fasting and were immediately centrifuged at 4°C and obtained plasma were stored at – 30°C for further analyses. Blood glucose concentration was measured by certified hospital laboratory applying standard clinical biochemistry methods. Insulin concentration was measured using IRMA methods (Immunotech, Czech Republic). Adiponectin and its fractions as well as c-terminal fragment of visfatin were estimated by EIA methods (ALPCO and Phoenix Pharmaceutical Inc., respectively). Plasma vaspin concentration was measured using ELISA kit (AdipoGen). Intra- and inter assay coefficient was below 10% for all investigated parameters. All adipokines and insulin levels were investigated in the Department of Neuroendocrinology, Centre of Postgraduate Medical Education in Warsaw.
In all subjects HOMA-IR was calculated according to the following formula: HOMA-IR = fasting glucose (mmol/dl) x fasting plasma insulin (μIU/ml)/22.5.
Statistical analysis
Statistica 6.1 was used for statistical analysis. Data are shown as means ± standard deviation (SD). The presence of normal distribution was analysed using Kolmogorow-Smirnoff test and differences in parametric variables were calculated with t-Student test. Non-parametric variables were analysed using Mann-Whitney U test. The Spearman test was applied to calculate correlations coefficients between estimated adipokines and biochemical parameters Significance level was defined as p < 0.05.
RESULTS
Data concerning clinical and biochemical parameters are presented in table 1. We found significant differences between extremely obese men and women in age, glucose levels and HOMA-IR. Men presented almost twofold higher HOMA-IR than women.
Table 1. Clinical and biochemical parameters of investigated groups.
ParameterMale
(n = 12)
Female
(n = 22)
p
Age (y)47.7 ± 7.139.6 ± 11.6< 0.05
BMI (kg/m2)45.6 ± 8.242.3 ± 5.5ns
Glucose (mg/dl)124.3 ± 39.596.8 ± 13.4< 0.05
Insulin (μIU/ml)28.8 ± 18.317.6 ± 9.4ns
HOMA-IR8.4 ± 4.84.3 ± 2.5< 0.05
ns – non significant

Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.

Płatny dostęp tylko do jednego, POWYŻSZEGO artykułu w Czytelni Medycznej
(uzyskany kod musi być wprowadzony na stronie artykułu, do którego został wykupiony)

Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu wraz z piśmiennictwem , należy wprowadzić kod:

Kod (cena 15 zł za 7 dni dostępu) mogą Państwo uzyskać, przechodząc na tę stronę.
Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.

 

 

Płatny dostęp do wszystkich zasobów Czytelni Medycznej

Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu wraz z piśmiennictwem oraz WSZYSTKICH około 7000 artykułów Czytelni, należy wprowadzić kod:

Kod (cena 35 zł za 30 dni dostępu) mogą Państwo uzyskać, przechodząc na tę stronę.
Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.

otrzymano: 2013-02-19
zaakceptowano do druku: 2013-03-27

Adres do korespondencji:
*Magdalena Walicka
Internal, Family Medicine and Metabolic Bone Disease Department Medical Centre of Postgraduate Education
ul. Czerniakowska 231, 00-416 Warszawa
tel.: +48 (22) 628-69-50, fax: +48 (22) 584-13-34
e-mail: m_walicka@wp.pl

Postępy Nauk Medycznych 4/2013
Strona internetowa czasopisma Postępy Nauk Medycznych